ALFREDO G. TORRES
Departments of Microbiology and Immunology and Pathology and The Sealy Center for Vaccine Development, University of Texas Medical Branch, Galveston, TX 77555-1070
*Phone: (409) 747-0189, Fax: (409) 747-6869, E-mail:
This e-mail address is being protected from spambots. You need JavaScript enabled to view it
EPEC strains are implicated in diarrhea in humans and are a leading cause of infantile diarrhea in developing countries. In industrialized countries, the frequency of these organisms has decreased, but they continue to be an important cause of diarrhea (103, 109). EPEC, the first pathogenic E. coli category to be associated with diarrhea, inhabits the small intestine and infects predominantly the proximal small intestine, either in the duodenum or the proximal jejunum, although there may be some colonic involvement due to overgrowth of the organism from the small intestine (120). The EPEC serotypes which are part of this E. coli pathotype are distinct from other pathogenic E. coli strains because they produce a distinct histopathological lesion on intestinal epithelial cells known as the A/E lesion (see below). A/E lesions are characterized by microvillus destruction, intimate adherence of bacteria to the intestinal epithelium, assembly of highly organized pedestal-like actin structures in the epithelial cells, and aggregation of polarized actin and other elements of the cytoskeleton at sites of bacterial attachment (reviewed in references 43, 74, and 103). The fluorescent actin staining test allows the identification of strains that produce A/E lesions through detection of aggregated actin filaments beneath the attached bacteria (Fig. 1A) (85). The ability to produce A/E lesions has also been detected in strains of enterohemorrhagic E. coli (EHEC) (Chapter Adhesins of Enterohemorrhagic Escherichia coli), Citrobacter rodentium, and other bacterial species (103).
In addition to differing in the presence or absence of the EAF plasmid, typical and atypical EPEC strains belong to different serotypes (150). Members of eleven serotypes are frequently considered to be typical EPEC strains (O55:H6, O55:NM, O86:H34, O111:H2, O111:NM, O114:H2, O119:H6, O119:NM, O127:H6, O142:H6, and O142:H34), and 14 serotypes correspond to atypical isolates (O26:H11, O26:NM, O55:H7, O55:NM, O55:H34, O86:H8, O111ac:H8, O111ac:NM, O111:H9, O111:NM, O111:H25, O119:H2, O125ac:H6, and O128:H2). One feature of some of these serotypes that may complicate the distinction between typical and atypical EPEC strains is the presence of EAF plasmid markers (150). For example, some strains react with a DNA probe directed to BFP genes but do not have a true EAF plasmid and other strains contain a large plasmid that does not contain the BFP operon (16). Therefore, in addition to the EAF plasmid, another characteristic to allow us to distinguish between typical and atypical EPEC serotypes is BFP production (150).
Typical and atypical EPEC strains also differ in their adherence patterns. The typical strains show only the LA pattern (Fig. 1B), but atypical strains may show a localized adherence-like (LAL) (51), diffuse adherence (DA) (Fig. 1C), or aggregative adherence (AA) (Fig. 1D) pattern. The sections following describe the various adherence factors produced by typical and atypical strains associated with the different adherence patterns and the distinctions within the intimin types, whose expression by the different serotypes has been linked to tissue tropism in the host (39, 112).
The proteins associated with the formation of the A/E lesion are encoded on a chromosomal PAI known as the locus of enterocyte effacement (LEE) (reviewed in reference 147). The first description of a gene in the LEE PAI associated with intimate adherence to epithelial cells was reported by Jerse et al. (68), who screened TnphoA mutants of EPEC for the loss of the A/E phenotype. The chromosomal gene identified in this study, eae, encodes intimin, an outer membrane protein needed for intimate adherence that is recognized by sera from volunteers convalescing from experimental EPEC infections (67, 68). Further analysis of additional mutations in this region which produced mutants that were negative for the A/E phenotype led McDaniel et al. (95) to identify a 35-kb locus containing several regions implicated in the formation of A/E lesions. The LEE is present in all EPEC strains as well as in other A/E phenotype-positive strains, including strains of EHEC (Chapter Adhesins of Enterohemorrhagic Escherichia coli) and other enteric pathogens (26, 95, 96, 165).
The complete sequence of the LEE from EPEC prototype strain E2348/69 has been determined (38). The EPEC LEE is 35,624 bp in length, with an average G+C content of 38.36%, and contains 41 predicted open reading frames (ORFs) corresponding to sequences of >50 amino acids arranged in at least five polycistronic operons (Fig. 2). For functional purposes, the EPEC LEE genes are divided into three regions. The middle region contains the eae, cesT, and tir genes. The eae gene encodes the intimin protein that mediates intimate attachment to the host cell (66, 67). Its receptor in the host cell is a bacterial protein named Tir (translocated intimin receptor) (79, 119). The Tir protein is translocated into the host cell via a type III secretion system (TTSS) and is implicated in several processes: it acts as a receptor for intimin, linking the bacterium to the host cell cytoskeleton, and functions in other signaling events within the host cell (Fig. 3) (17, 79). The cesT gene encodes the protein CesT, which functions as a bivalent chaperone required for the translocation of both Tir and Map (1, 21, 34).
It has been clearly established that intimin mediates the intimate adherence to target eukaryotic cells upon interaction with Tir and that, upon this interaction, host cell signaling events are triggered that lead to cytoskeletal protein accumulation beneath the adherent bacteria ( Fig. 3B) (reviewed in references 17 and 78). Further, the concept of how EPEC strains causing A/E lesions adhere to mammalian cells has been enhanced by the description of the crystal structure of intimin coupled to the Tir receptor (92). The current model indicates that, once translocated, the Tir protein spans the host cell membrane, adopting a hairpin loop structure featuring both its N and C termini in the host cytoplasm and a central extracellular domain that binds intimin (9, 91, 92). In addition to serving as a receptor for intimin, the Tir protein is capable of interacting with host cytoskeletal and signaling components by using its N- and C-terminal domains located in the host cell cytoplasm (Fig. 3B). The numerous host proteins that accumulate in the A/E lesion around Tir and the mechanisms by which Tir exploits the host cell signaling networks resulting in actin cytoskeletal rearrangements are reviewed extensively in the chapter dedicated to EPEC (Chapter Enteropathogenic Escherichia coli).
EPEC intimin is a 94-kDa outer membrane protein (939 amino acids) that can be subdivided into a flexible N-terminal region (including a periplasmic domain, residues 40 to 188), a central membrane-integral β barrel (residues 189 to 549), and a surface-exposed C-terminal region (including four extracellular domains named D0 to D3, residues 550 to 939), where the receptor binding activity resides (53, 92). Originally, the receptor binding region was mapped to a region comprising the C-terminal 280 amino acids of intimin (77). Further crystallographic studies indicated that the last 190 amino acids within this region mediate this binding. The C-terminal 190 amino acids of intimin comprise an N-terminal immunoglobulin domain that is coupled to a novel C-type lectin domain, which in turn forms a flexible rod that extends from the bacterial surface and serves as a tip that binds the target cell (9, 90, 92). Furthermore, a direct link between intimin binding and Tir clustering has been also demonstrated (149). The association of intimin with Tir triggers a host cell response leading to pedestal formation (Fig. 3B). Although the formation of actin pedestals by EPEC is a phenotype best characterized in vitro in epithelial cell lines, pedestal formation correlates with the ability of the A/E organisms to colonize the intestine and cause disease in human and other animal hosts (reviewed in reference 103).
In addition to the interaction of intimin with its primary receptor, Tir, and the subsequent triggering of host cellular responses, there is evidence indicating that intimin promotes initial adherence by binding to endogenous host cell receptors independently of its interaction with Tir. An initial study reported that intimin from EPEC can bind β1-chain integrins in vitro (41), but a subsequent study challenged these results and indicated that these host cell proteins are not essential for intimin-mediated cell attachment or EPEC-mediated actin polymerization (90). Although the location of β1-integrins in the basolateral membranes of intestinal epithelial cells would seem to preclude interaction with EPEC on the apical membrane, a recent study showed that EPEC induces alterations in tight junctions, resulting in redistribution of β1-integrin and other basolateral membrane proteins to the apical cell surface, thereby providing them with an opportunity to interact with EPEC intimin (100). Despite these discrepant results, additional indirect evidence favors the concept that intimin interacts with an additional eukaryotic cell receptor. Such evidence includes intimin-mediated tissue tropism (see below), sequence divergence in the region corresponding to the intimin domain mediating receptor binding, and the results of mutagenesis analysis of this region indicating that the domain mediating intimin binding to Tir is separate from the domain mediating adherence to host cells (42). Moreover, the fact that purified intimin displays biological activity provides additional evidence indicating that intimin binds directly to host cells, inducing colonic hyperplasia in mice (58) and activating T cells (52).
EPEC intimin has been associated with the pattern of colonization and tissue tropism of the host (112), and the correlation between the expression of different types of intimin and tissue tropism has been suggested by recent data indicating that differences in the amino acid sequences of the intimin proteins influence the patterns of colonization in the host (39, 112). These observations have been demonstrated experimentally using in vitro human intestinal organ cultures (IVOC), and it was found that EPEC intimin confers specificity for the human proximal and distal small intestine as well as the follicle-associated epithelium of Peyer’s patches (FAE) (112). Furthermore, it has been shown that intimin is required for colonization by EPEC and pathogenesis of EPEC infection in humans (32). Intimin proteins of EHEC (Chapter Adhesins of Enterohemorrhagic Escherichia coli) and EPEC strains show a high level of conservation in the N-terminal regions and variability in the last C-terminal 280 amino acids of the proteins. The antigenic polymorphism in the C-terminal region, where binding to enterocytes and Tir occurs, has led to the classification of EPEC and EHEC intimins into at least 10 types (reviewed in reference 148), and typical and atypical EPEC strains express different intimin types (Table 1).
The initial studies using genetic and immunological approaches provided evidence for the existence of at least four distinct intimin types in EPEC and EHEC strains known as intimin α, β, γ, and δ (2, 3). A subsequent study revealed the presence of a fifth type, intimin ε, in EHEC strains of serogroup O103 (110). It has also been proposed that intimins α, β, and γ can be further subdivided based on restriction analysis into α1, α2, β1, β2, γ1, and γ2 (β2 is identical to δ) (110). Recently, other independent studies have proposed that additional intimin types classified based only on subtle differences at the nucleotide level can be found in other strains of EPEC or EHEC. These new groups have been classified as intimins ζ, η, θ, ι, κ, λ, μ, ν, and ξ (13, 14, 70, 137, 163).
Intimin α is expressed by typical strains from the clonal group designated EPEC 1, as well as serotypes O142:H6 and O142:H34, and by atypical EPEC strains of serotypes O111:H9 (motile and nonmotile) and O125ac:H6 (Table 1). Its expression has been shown to confer specificity for the human proximal and distal small intestine as well as for the FAE (114). Intimin β is associated with human and animal EPEC 2 isolates, typical EPEC strains of serotypes O114:H2, O119:H6 (motile and nonmotile), O128:H2, and O126:H2, and atypical EPEC strains of serotypes O26:H11 (motile and nonmotile), O119:H2, and O91:H7. By using a rabbit diarrheagenic E. coli (RDEC-1) strain, it has been shown that intimin β expression correlates with colonization of the rabbit Peyer’s patch lymphoid follicles (18). As for intimin γ, its expression correlates with colonization of the human ileal FAE (39, 112) and it is found in typical EPEC strains of serotypes O119:H6 (motile and nonmotile) and O55:H− and in atypical EPEC strains of serotypes O55:H7 (motile and nonmotile), O111ac:H8 (motile and nonmotile), O55:H34, O101:H−, and O116:H33. Intimin δ has been found in typical EPEC O86:H34 and atypical EPEC O88:H5, but the tissue specificity of this intimin has not been determined. Although intimin ε is expressed by human and animal EHEC strains other than those of serogroup O157 (Chapter Adhesins of Enterohemorrhagic Escherichia coli) and atypical EPEC O103:H−, the tissue distribution of these strains is similar to that observed with intimin γ of EHEC O157:H7 (40). Finally, some intimin alleles not frequently found in human isolates have been described in atypical EPEC strains (intimin ζ in O111:H9, intimin θ in O156:H8, and an untypeable intimin in O127:H40). The host and tissue distributions of EPEC and EHEC are probably multifactorial, but characterization of the different intimin types may yield important information regarding tissue tropism.
Typical EPEC strains produce a characteristic adherence pattern, called LA, in tissue culture cells (124, 154). In this pattern, bacteria bind to localized areas of the cell surface, forming compact microcolonies (bacterial clusters) that can be visualized after bacteria have been in contact with cells for 3 h (Fig. 1A and Fig. 1B). This phenomenon is associated with the presence of the large EPEC adherence factor (EAF) plasmid, which carries a cluster of genes that encode type IV fimbriae known as BFP (48), which interconnect bacteria within microcolonies and thus promote their stabilization. In addition, the EAF plasmid carries the Per (plasmid-encoded regulator) regulatory locus (perABC), which is known to be an activator of the plasmid-located bfp operon and also a regulator of the chromosomal LEE genes (98, 143). The EAF plasmid is not essential for the formation of A/E lesions, although its presence enhances the efficiency of lesion formation due to the presence of the Per regulon (98; Chapter Enteropathogenic Escherichia coli), as well as BFP, whose role in cell adhesion would similarly increase the efficiency of A/E lesion formation (43).
Initial in vitro experiments employing cultured epithelial cells of nonintestinal origin have shown that BFP mediate EPEC initial binding, the formation of microcolonies, and interbacterial interactions that allow formation of three-dimensional bacterial aggregates at a later stage of infection (48, 133, 134). A subsequent study employing freshly harvested human intestinal mucosa in the in vitro organ culture (IVOC) system indicated that BFP are involved in the development of the three-dimensional structure of the microcolonies after intimate attachment rather than in the initial adherence (57). The apparent discrepancy in these results has been evaluated using an intestinal cell line, Caco-2 cells, as the in vitro system (141, 142). These studies suggested that EPEC binding occurs through direct interaction with the host cell rather than an already-formed EPEC microcolony and that BFP provide an important function in the cell type-dependent adherence of EPEC and in the progression to the later steps in EPEC adherence (141, 142). A recent study by Cleary et al. (19) also presented evidence showing that BFP can mediate the rapid adherence of EPEC to Caco-2 cells. This study showed that an EPEC intimin mutant strain which cannot form A/E lesions but expresses BFP adheres to human intestinal explants ex vivo, providing further support for a cell adhesion role for BFP. Although it is clear that BFP are involved in interbacterial adherence in the LA pattern, there is no conclusive evidence that BFP mediate actual adherence to epithelial cells (reviewed in reference 107). In addition to the ability for LA, BFP-expressing EPEC strains exhibit autoaggregation, forming large clusters when grown in tissue culture medium (154). The autoaggregation phenotype is lost in a bfp mutant, and the phenotype is restored by complementation. Indeed, all mutants described to date that are unable to make BFP are unable to perform autoaggregation and to produce LA patterns (4, 118). Regardless of the specific role of these fimbriae in adherence, the importance of BFP as a virulence factor in human EPEC infection pathogenesis has been clearly demonstrated by a volunteer trial in which a bfp mutant was ca. 200-fold less virulent than the wild-type BFP-positive parent strain (12).
Pilus biogenesis and microcolony dispersal are energy-requiring processes, and the putative nucleotide binding proteins encoded by bfpD and bfpF genes are required to provide the energy for these events (Fig. 2). BfpD is a cytoplasmic protein required for pilus biogenesis (4, 12, 118), and a mechanism by which BfpD transduces mechanical energy to the biogenesis machine has been recently proposed (24). BfpF is also a cytoplasmic protein with homology to the PilT protein found in Pseudomonas aeruginosa, which is required for twitching motility and pilus-specific bacteriophage entry (reviewed in reference 108). Mutation in the bfpF gene results in increased adherence and hyperpiliation, suggesting that this protein is involved in pilus retraction (5, 12). BFP aggregation and dispersal have been shown to take place on cultured epithelial cells (87). In these conditions, BfpF is required for morphological changes in BFP from thin to thick pili as infection proceeds, and these changes lead to loose aggregation of bacteria. BfpF is thought to allow unraveling of these intertwined pilus structures (87).
Several type IV pili have been shown to play an important role in mediating bacteria-host cell adherence and have been recognized as true adhesins, e.g., the PilC tip adhesin of Neisseria gonorrhoeae type IV pili (81, 121) and the P. aeruginosa type IV pili which mediate binding via an epitope exposed at the pilus tip (55, 89). Not all of the members of the type IV pilus family have been demonstrated to bind to cells. For example, while the toxin-coregulated pilus of Vibrio cholerae is required for colonization in both the infant mouse model and humans (56), the involvement of the toxin-coregulated pilus in the adhesion of these organisms to the intestinal epithelium has never been demonstrated (136). Similarly, although it seems evident that BFP mediate interbacterial interactions, it is not clear whether BFP act as a host cell adhesin. Although mutations that block formation of BFP and anti-BFP serum also inhibit LA (30, 48), these manipulations may reduce the number of adherent bacteria and influence the pattern of adherence by interfering with interbacterial interactions rather than with bacterium-host cell binding.
If BFP act as an adhesin participating in EPEC interactions with the intestinal epithelium, then they should have a specific receptor and blocking interactions with the receptor should, in theory, inhibit EPEC adherence. A large number of candidate BFP receptors have been proposed, including several oligosaccharides as potential BFP targets. Although one study reported that LA to HeLa cells can be completely inhibited by N-acetylgalactosamine (123), another group reported that EPEC strains that exhibit LA bind to asialo-GM1, asialo-GM2, globoside, and lacto-N-neotetraose and that the minimal receptor contains GalNAc-β-1–4 Gal moieties (62). Other studies have reported that fucosylated tetra- and pentasaccharides (20) and N-acetyllactosamine conjugated to bovine serum albumin and Lewis X-bovine serum albumin inhibit the LA pattern (153). However, immunoblotting for bundlin indicated that the inhibitory effects of these lactosyl glycans were associated with down regulation of bfpA and, thus, may not have involved competition with the target. Furthermore, other studies have implicated phosphatidylethanolamine (PE) as a potential target of BFP (8, 159). The investigators of these studies showed a correlation between the ability to bind PE and the presence of the bfpA gene in a number of strains; however, the strength of the interaction between BFP and PE has not been reported. Even though these studies suggest that LA is a phenomenon that results from direct interaction between an adhesin of typical EPEC and host cells, it remains unclear whether or not BFP are that EPEC adhesin.
The early and later events in EPEC adhesion and pathogenesis have been proposed to occur in distinct stages (Fig. 3) (28, 31, 108). This model remains controversial and probably artificial, particularly because the early events in EPEC adhesion are poorly understood and the role of several potential adhesins has not been completely elucidated. In the initial stage and under the correct environmental conditions, EPEC cells express BFP, the intimate adhesin intimin, surface-associated EspA filaments, and flagella; the expression of these determinants is dependent on both plasmid and chromosomal genes (Fig. 3A). In this stage, EPEC adhesion may involve binding of intimin to a host cell receptor, such as nucleolin, and binding of the EspA filament directly to the cell or via secreted EspB and EspD proteins. The role of flagella and BFP in adhesion to the host cells still remains controversial. EPEC cells adhering to epithelial cells will use the TTSS to inject the translocated intimin receptor (Tir) and an as-yet-undetermined number of effector molecules directly into the host cell. Effector molecules activate cell signaling pathways, causing alterations in the host cell cytoskeleton and resulting in the depolymerization of actin and the loss of microvilli. Tir is modified by the action of both protein kinase A (54) and redundant tyrosine protein kinases (135) and is inserted into the host membrane. In a subsequent stage (Fig. 3B), the EspA filaments are lost from the bacterial cell surface, the bacterial adhesin intimin binds to the modified Tir, resulting in intimate attachment, and accumulation of actin and other cytoskeletal elements occurs beneath the site of bacterial adherence. A massive accumulation of cytoskeletal elements at the site of bacterial attachment results in the formation of the characteristic EPEC pedestal structure. The translocated effector molecules disrupt host cell processes, resulting in the loss of tight-junction integrity and mitochondrial function, leading to both an increase in intestinal permeability with electrolyte loss and eventual cell death (Chapter Enteropathogenic Escherichia coli ).
EPEC strains possess other surface-exposed structures such as flagella. Epidemiological studies have shown that EPEC strains isolated throughout the world express a restricted number of flagellar antigen types, raising the possibility that this surface structure may perform an additional function besides its role in motility. This idea was investigated by Girón et al. (49), who reported that flagella of EPEC are directly involved in the adherence of these bacteria to cultured HeLa cells. The investigators also demonstrated that EPEC flagellum expression is induced by a molecule secreted by the eukaryotic cells and that a molecular cross talk exists between flagella and other virulence-associated systems in EPEC (49). The eukaryotic factor inducing flagellum expression remains unknown, and a recent report found no evidence for such a factor or for production of flagella by EPEC adherent to HeLa cells (160). Recently, another study reported the production of flagella by adherent EPEC but could not confirm a role of flagella in adherence (19). As shown by these conflicting results, there is obviously much additional work to be done to determine the precise role of flagella in adherence. In addition to its potential role as an adhesin, it has been demonstrated that the EPEC flagellar filament and its flagellin monomer can induce the activation of interleukin-8 (IL-8) in intestinal epithelial cells, raising the possibility that EPEC flagellin plays an important role in the intestinal inflammatory response during infection (164). Although flagella of EPEC strains can trigger IL-8 secretion, it has been proposed that these pathogens, in fact, inhibit this response in a TTSS-dependent manner that apparently does not require the known LEE effector proteins (reviewed in reference 25).
It has been proposed that a number of other adhesins mediate EPEC-host cell interactions. Recent completion of the genomic sequencing of EPEC strain E2348/69 (http://www.sanger.ac.uk/cgi-bin/blast/submitblast/escherichia_shigella) has revealed the presence of at least 9 regions with homology to potential fimbrial adhesin gene clusters and 10 regions encoding putative nonfimbrial adhesins in addition to the LEE-encoded intimin. One of these regions encodes the type I fimbriae, which have been investigated as a possible EPEC adhesin. Although volunteers challenged with wild-type EPEC developed an immune response against type I fimbriae (75), mutagenesis of the type I fimbriae in EPEC strain E2348/69 failed to show any effect on levels or patterns of adherence of EPEC in vitro (35 ). The role of the EPEC type I fimbriae in human enteric infections is still unclear.
A second region in the chromosome of EPEC E2348/69 has conserved fimbrial genes that encode homologs of the long polar fimbriae (LPF) (139). LPF were first described in Salmonella enterica serovar Typhimurium (Chapter Salmonella Intestinal Infections) and have been shown to direct the attachment of S. enterica serovar Typhimurium to murine Peyer’s patches in vivo (10, 11). The lpf gene cluster is able to mediate microcolony formation by EHEC O157:H7 (Chapter Adhesins of Enterohemorrhagic Escherichia coli) and the adherence of nonfimbriated E. coli ORN172 to epithelial cells (145, 146) and to contribute to the colonization and persistence by E. coli O157:H7 in swine and sheep (69). Furthermore, genes homologous to lpf genes have been identified in rabbit-specific EPEC strains (105) and in invasive E. coli isolates associated with extraintestinal infections (60). While lpf appeared to play a role in the early stages of rabbit-specific EPEC infection in rabbits and is essential for the development of severe diarrhea (105), the lpf of an invasive E. coli O78 strain has been shown to be important only for adherence to epithelial cells in vitro (60). In the case of the lpf region of typical EPEC, it has been found that the cluster contains five ORFs (lpfABCDE) of which the predicted proteins are homologous (about 60% at the amino acid level) to the Salmonella LPF. To determine whether this operon is essential for adherence to IVOC, the lpfABCD genes were deleted from EPEC strain E2348/69 by allelic exchange. Initial analysis of the resulting EPEC ΔlpfABCD strain in IVOC studies showed no change in adherence on small intestinal mucosa compared to that of the wild type. Furthermore, the EPEC lpf mutant showed a normal adherence pattern and formed A/E lesions on HEp-2 cells, suggesting that this lpf gene cluster is not necessary for EPEC adherence and for A/E lesion formation on human biopsy specimens (139). However, there is obviously much additional work to be done to determine the precise role of EPEC LPF in adherence.
Finally, EPEC has been shown to exhibit a type III secretion-dependent, contact-mediated, hemolytic activity requiring the EspA, EspB, and EspD secreted proteins (156). EspA is the major component of a large filamentous structure that is proposed to provide a conduit between the type III translocon and a host cell membrane pore (86). Experimental evidence indicates that EspA filaments mediate the binding of EPEC to red blood cells and that close contact is not a requirement for EPEC-induced hemolysis (129). More importantly, Cleary et al. (19) recently showed that EspA participates in the initial attachment to the brush border of Caco-2 cells. While BFP have been proposed to be the predominant adhesin in the initial attachment of strains expressing both BFP and EspA, the EspA filament has been proposed to be the adhesin mediating initial adherence by EPEC strains that lack BFP (19).
Significant progress has been made in the past two decades in understanding the interaction of EPEC with intestinal epithelial cells. The elucidation of the interaction between Tir and intimin in EPEC and then in other A/E lesion-producing E. coli strains has been one of the key findings to establish a new paradigm in cellular microbiology regarding pathogenic bacteria and host cell interactions. A key issue that still remains controversial is the concept of BFP- and flagellum-mediated adherence to host cell receptors. It has also been established that intimin mediates the intimate adherence to target epithelial cells in culture and IVOC and is a virulence factor of major importance in disease. It is also known that intimin binds in a dose-dependent manner to cells that have been preinfected with EPEC to allow the delivery of Tir. However, the specificity, saturability, and strength of the intimin-Tir interaction have not been clearly established. Further, EPEC intimin also binds to nucleolin in a Tir-independent manner and additional studies with purified proteins are required to establish the significance of this interaction. As a result of cumulative evidence provided by several laboratories, intimin satisfies any criteria to be considered as the major EPEC adhesin. However, further details of the interactions between intimin and Tir or other receptors need to be investigated to establish the relative roles of these interactions, especially in the initial adhesion of EPEC cells.
Furthermore, new fimbrial as well as nonfimbrial adhesins have been found in typical and atypical EPEC strains associated with adhesion. However, many of the adhesion studies with these novel fimbrial and nonfimbrial factors have been carried out in vitro using tissue culture cells not derived from intestinal cells (e.g., HeLa or HEp-2 cells). Even though such experiments provide information about the role played by these factors in adhesion in vitro, the relevance of these findings for in vivo infection are limited and still need to be validated in vitro with intestinal epithelial cells and ex vivo with the IVOC system.
Additional and important basic questions in EPEC adhesion still remain unanswered, such as the specific role of the EspA filament during the interaction with the epithelial cells. It is clear that in order to deliver Tir into host cells, there must be direct contact between the bacteria and host through the TTSS. However, it is not clear whether EspA binds to a cellular receptor or whether EspD and/or EspB mediates this contact by inserting itself into the membrane. Furthermore, if EspA, EspB, and EspD directly interact with the host cells, do they have a specific receptor(s)? Are EspD and EspB first secreted into the extracellular environment from which they insert themselves into the host cell membrane and subsequently bind to EspA, or do they sit at the tip of the EspA filament and bind to or insert themselves into the host cell?
Further characterization of the adherence factors as well as the definition of the specific interactions between the adhesins and their receptors will not only provide a better understanding of the pathogenesis of infections with EPEC strains but will also reveal attractive targets for novel therapeutics and vaccine development.
References
1. Abe, A., M. de Grado, R. A. Pfuetzner, C. Sanchez-Sanmartin, R. Devinney, J. L. Puente, N. C. Strynadka, and B. B. Finlay. 1999. Enteropathogenic Escherichia coli translocated intimin receptor, Tir, requires a specific chaperone for stable secretion. Mol. Microbiol. 33:1162–1175.[PubMed] [CrossRef]
2. Adu-Bobie, J., G. Frankel, C. Bain, A. G. Goncalves, L. R. Trabulsi, G. Douce, S. Knutton, and G. Dougan. 1998. Detection of intimins alpha, beta, gamma, and delta, four intimin derivatives expressed by attaching and effacing microbial pathogens. J. Clin. Microbiol. 36:662–668.[PubMed]
3. Agin, T. S., and M. K. Wolf. 1997. Identification of a family of intimins common to Escherichia coli causing attaching-effacing lesions in rabbits, humans, and swine. Infect. Immun. 65:320–326.[PubMed]
4. Anantha, R. P., K. D. Stone, and M. S. Donnenberg. 2000. Effects of bfp mutations on biogenesis of functional enteropathogenic Escherichia coli type IV pili. J. Bacteriol. 182:2498–2506.[PubMed] [CrossRef]
5. Anantha, R. P., K. D. Stone, and M. S. Donnenberg. 1998. The role of BfpF, a member of the PilT family of putative nucleotide-binding proteins, in type IV pilus biogenesis and in interactions between enteropathogenic Escherichia coli and host cells. Infect. Immun. 66:122–131.
6. Badea, L., S. Doughty, L. Nicholls, J. Sloan, R. M. Robins-Browne, and E. L. Hartland. 2003. Contribution of Efa1/LifA to the adherence of enteropathogenic Escherichia coli to epithelial cells. Microb. Pathog. 34:205–215.[PubMed] [CrossRef]
7. Baldini, M. M., J. B. Kaper, M. M. Levine, D. C. Candy, and H. W. Moon. 1985. Plasmid-mediated adhesion in enteropathogenic Escherichia coli. J. Pediatr. Gastroenterol. Nutr. 2:534–538. [CrossRef]
8. Barnett Foster, D., D. Philpott, M. Abul-Milh, M. Huesca, P. M. Sherman, and C. A. Lingwood. 1999. Phosphatidylethanolamine recognition promotes enteropathogenic E. coli and enterohemorrhagic E. coli host cell attachment. Microb. Pathog. 27:289–301.[PubMed] [CrossRef]
9. Batchelor, M., S. Prasannan, S. Daniell, S. Reece, I. Connerton, G. Bloomberg, G. Dougan, G. Frankel, and S. Matthews. 2000. Structural basis for recognition of the translocated intimin receptor (Tir) by intimin from enteropathogenic Escherichia coli. EMBO J. 19:2452–2464.[PubMed] [CrossRef]
10. Baumler, A. J., and F. Heffron. 1995. Identification and sequence analysis of lpfABCDE, a putative fimbrial operon of Salmonella typhimurium. J. Bacteriol. 177:2087–2097.[PubMed]
11. Baumler, A. J., R. M. Tsolis, and F. Heffron. 1996. The lpf fimbrial operon mediates adhesion of Salmonella typhimurium to murine Peyer's patches. Proc. Natl. Acad. Sci. USA 93:279–283.[PubMed] [CrossRef]
12. Bieber, D., S. W. Ramer, C. Y. Wu, W. J. Murray, T. Tobe, R. Fernandez, and G. K. Schoolnik. 1998. Type IV pili, transient bacterial aggregates, and virulence of enteropathogenic Escherichia coli. Science 280:2114–2118.[PubMed] [CrossRef]
13. Blanco, J. E., M. Blanco, M. P. Alonso, A. Mora, G. Dahbi, M. A. Coira, and J. Blanco. 2004. Serotypes, virulence genes and intimin types of Shiga toxin (verotoxin)-producing Escherichia coli isolates from human patients: prevalence in Lugo (Spain) from 1992 through 1999. J. Clin. Microbiol. 42:311–319.[PubMed] [CrossRef]
14. Blanco, M., J. E. Blanco, A. Mora, J. Rey, J. M. Alonso, M. Hermoso, J. Hermoso, M. P. Alonso, G. Dhabi, E. A. González, M. I. Bernárdez, and J. Blanco. 2003. Serotypes, virulence genes, and intimin types of Shiga toxin (verotoxin)-producing Escherichia coli isolates from healthy sheep in Spain. J. Clin. Microbiol. 41:1351–1365.[PubMed] [CrossRef]
15. Blank, T. E., H. Zhong, A. L. Bell, T. S. Whittam, and M. S. Donnenberg. 2000. Molecular variation among type IV pilin (bfpA) genes from diverse enteropathogenic Escherichia coli strains. Infect. Immun. 68:7028–7038.[PubMed] [CrossRef]
16. Bortolini, M. R., L. R. Trabulsi, R. Keller, G. Frankel, and V. Sperandio. 1999. Lack of expression of bundle-forming pili in some clinical isolates of enteropathogenic Escherichia coli (EPEC) is due to a conserved large deletion in the bfp operon. FEMS Microbiol. Lett. 179:169–174.[PubMed] [CrossRef]
17. Campellone, K. G., and J. M. Leong. 2003. Tails of two Tirs: actin pedestal formation by enteropathogenic E. coli and enterohemorrhagic E. coli O157:H7. Curr. Opin. Microbiol. 6:82–90.[PubMed] [CrossRef]
18. Cantey, J. R., and L. R. Inman. 1981. Diarrhea due to Escherichia coli strain RDEC-1 in the rabbit: the Peyer's patch as the initial site of attachment and colonization. J. Infect. Dis. 143:440–446.[PubMed]
19. Cleary, J., L. C. Lai, R. K. Shaw, A. Straatman-Iwanowska, M. S. Donnenberg, G. Frankel, and S. Knutton. 2004. Enteropathogenic Escherichia coli (EPEC) adhesion to intestinal epithelial cells: role of bundle-forming pili (BFP), EspA filaments and intimin. Microbiology 150:527–538.[PubMed] [CrossRef]
20. Cravioto, A., A. Tello, H. Villafán, J. Ruiz, S. Del Vedovo, and J. R. Neeser. 1991. Inhibition of localized adhesion of enteropathogenic Escherichia coli to HEp-2 cells by immunoglobulin and oligosaccharide fractions of human colostrum and breast milk. J. Infect. Dis. 163:1247–1255.[PubMed]
21. Creasey, E. A., R. M. Delahay, A. A. Bishop, R. K. Shaw, B. Kenny, S. Knutton, and G. Frankel. 2003. CesT is a bivalent enteropathogenic Escherichia coli chaperone required for translocation of both Tir and Map. Mol. Microbiol. 47:209–221.[PubMed] [CrossRef]
22. Creasey, E. A., D. Friedberg, R. K. Shaw, T. Umanski, S. Knutton, I. Rosenshine, and G. Frankel. 2003. CesAB is an enteropathogenic Escherichia coli chaperone for the type-III translocator proteins EspA and EspB. Microbiology 149:3639–3647.[PubMed] [CrossRef]
23. Crowther, L. J., R. P. Anantha, and M. S. Donnenberg. 2004. The inner membrane subassembly of the enteropathogenic Escherichia coli bundle-forming pilus machine. Mol. Microbiol. 52:67–79.[PubMed] [CrossRef]
24. Crowther, L. J., A. Yamagata, L. Craig, J. A. Tainer, and M. S. Donnenberg. 2005. The ATPase activity of BfpD is greatly enhanced by zinc and allosteric interactions with other Bfp proteins. J. Biol. Chem. 280:24839–24848.[PubMed] [CrossRef]
25. Dean, P., M. Maresca, and B. Kenny. 2005. EPEC's weapons of mass subversion. Curr. Opin. Microbiol. 8:28–34.[PubMed] [CrossRef]
26. Deng, W., Y. Li, B. A. Vallance, and B. B. Finlay. 2001. Locus of enterocyte effacement from Citrobacter rodentium: sequence analysis and evidence for horizontal transfer among attaching and effacing pathogens. Infect. Immun. 69:6323–6335.[PubMed] [CrossRef]
27. Deng, W., J. L. Puente, S. Gruenheid, Y. Li, B. A. Vallance, A. Vazquez, J. Barba, J. A. Ibarra, P. O'Donnell, P. Metalnikov, K. Ashman, S. Lee, D. Goode, T. Pawson, and B. B. Finlay. 2004. Dissecting virulence: systematic and functional analyses of a pathogenicity island. Proc. Natl. Acad. Sci. USA 101:3597–3602.[PubMed] [CrossRef]
28. DeVinney, R., D. G. Knoechel, and B. B. Finlay. 1999. Enteropathogenic Escherichia coli: cellular harassment. Curr. Opin. Microbiol. 2:83–88.[PubMed] [CrossRef]
29. Devinney, R., I. Nisan, S. Ruschkowski, I. Rosenshine, and B. B. Finlay. 2001. Tir tyrosine phosphorylation and pedestal formation are delayed in enteropathogenic Escherichia coli sepZ::TnphoA mutant 30-5-1(3). Infect. Immun. 69:559–563.[PubMed] [CrossRef]
30. Donnenberg, M. S., J. A. Giron, J. P. Nataro, and J. B. Kaper. 1992. A plasmid-encoded type IV fimbrial gene of enteropathogenic Escherichia coli associated with localized adherence. Mol. Microbiol. 6:3427–3437.[PubMed] [CrossRef]
31. Donnenberg, M. S., and J. B. Kaper. 1992. Enteropathogenic Escherichia coli. Infect. Immun. 60:3953–3961.[PubMed]
32. Donnenberg, M. S., C. O. Tacket, S. P. James, G. Losonsky, J. P. Nataro, S. S. Wasserman, J. B. Kaper, and M. M. Levine. 1993. Role of the eaeA gene in experimental enteropathogenic Escherichia coli infection. J. Clin. Investig. 92:1412–1417.[PubMed] [CrossRef]
33. Donnenberg, M. S., H. Z. Zhang, and K. D. Stone. 1997. Biogenesis of the bundle-forming pilus of enteropathogenic Escherichia coli: reconstitution of fimbriae in recombinant E. coli and role of DsbA in pilin stability—a review. Gene 192:33–38.[PubMed] [CrossRef]
34. Elliott, S. J., S. W. Hutcheson, M. S. Dubois, J. L. Mellies, L. A. Wainwright, M. Batchelor, G. Frankel, S. Knutton, and J. B. Kaper. 1999. Identification of CesT, a chaperone for the type III secretion of Tir in enteropathogenic Escherichia coli. Mol. Microbiol. 33:1176–1189.[PubMed] [CrossRef]
35. Elliott, S. J., and J. B. Kaper. 1997. Role of type 1 fimbriae in EPEC infections. Microb. Pathog. 23:113–118.[PubMed] [CrossRef]
36. Elliott, S. J., E. O. Krejany, J. L. Mellies, R. M. Robins-Browne, C. Sasakawa, and J. B. Kaper. 2001. EspG, a novel type III secreted protein from enteropathogenic Escherichia coli with similarities to VirA of Shigella. Infect. Immun. 69:4027–4033. [CrossRef]
37. Elliott, S. J., V. Sperandio, J. A. Giron, S. Shin, J. L. Mellies, L. Wainwright, S. W. Hutcheson, T. K. McDaniel, and J. B. Kaper. 2000. The locus of enterocyte effacement (LEE)-encoded regulator controls expression of both LEE- and non-LEE-encoded virulence factors in enteropathogenic and enterohemorrhagic Escherichia coli. Infect. Immun. 68:6115–6126.[PubMed] [CrossRef]
38. Elliott, S. J., L. A. Wainwright, T. K. McDaniel, K. G. Jarvis, Y. K. Deng, L. C. Lai, B. P. McNamara, M. S. Donnenberg, and J. B. Kaper. 1998. The complete sequence of the locus of enterocyte effacement (LEE) from enteropathogenic Escherichia coli E2348/69. Mol. Microbiol. 28:1–4.[PubMed] [CrossRef]
39. Fitzhenry, R. J., D. J. Pickard, E. L. Hartland, S. Reece, G. Dougan, A. D. Phillips, and G. Frankel. 2002. Intimin type influences the site of human intestinal mucosal colonisation by enterohaemorrhagic Escherichia coli O157:H7. Gut 50:180–185.[PubMed] [CrossRef]
40. Fitzhenry, R. J., M. P. Stevens, C. Jenkins, T. S. Wallis, R. Heuschkel, S. Murch, M. Thomson, G. Frankel, and A. D. Phillips. 2003. Human intestinal tissue tropism of intimin epsilon O103 Escherichia coli. FEMS Microbiol. Lett. 218:311–316.[PubMed] [CrossRef]
41. Frankel, G., O. Lider, R. Hershkoviz, A. P. Mould, S. G. Kachalsky, D. C. Candy, L. Cahalon, M. J. Humphries, and G. Dougan. 1996. The cell-binding domain of intimin from enteropathogenic Escherichia coli binds to beta1 integrins. J. Biol. Chem. 271:20359–20364.[PubMed] [CrossRef]
42. Frankel, G., A. D. Phillips, M. Novakova, M. Batchelor, S. Hicks, and G. Dougan. 1998. Generation of Escherichia coli intimin derivatives with differing biological activities using site-directed mutagenesis of the intimin C-terminus domain. Mol. Microbiol. 29:559–570.[PubMed] [CrossRef]
43. Frankel, G., A. D. Phillips, I. Rosenshine, G. Dougan, J. B. Kaper, and S. Knutton. 1998. Enteropathogenic and enterohemorrhagic Escherichia coli: more subversive elements. Mol. Microbiol. 30:911–921.[PubMed] [CrossRef]
44. Garcia, M. I., P. Gounon, P. Courcoux, A. Labigne, and C. Le Bouguenec. 1996. The afimbrial adhesive sheath encoded by the afa-3 gene cluster of pathogenic Escherichia coli is composed of two adhesins. Mol. Microbiol. 19:683–693.[PubMed] [CrossRef]
45. Garcia, M. I., M. Jouve, J. P. Nataro, P. Gounon, and C. Le Bouguenec. 2000. Characterization of the AfaD-like family of invasins encoded by pathogenic Escherichia coli associated with intestinal and extra-intestinal infections. FEBS Lett. 479:111–117.[PubMed] [CrossRef]
46. Garmendia, J., G. Frankel, and V. F. Crepin. 2005. Enteropathogenic and enterohemorrhagic Escherichia coli infections: translocation, translocation, translocation. Infect. Immun. 73:2573–2585.[PubMed] [CrossRef]
47. Genin, S., and C. A. Boucher. 1994. A superfamily of proteins involved in different secretion pathways in gram-negative bacteria: modular structure and specificity of the N-terminal domain. Mol. Gen. Genet. 243:112–118.[PubMed] [CrossRef]
48. Girón, J. A., A. S. Ho, and G. K. Schoolnik. 1991. An inducible bundle-forming pilus of enteropathogenic Escherichia coli. Science 254:710–713.[PubMed] [CrossRef]
49. Girón, J. A., A. G. Torres, E. Freer, and J. B. Kaper. 2002. The flagella of enteropathogenic Escherichia coli mediate adherence to epithelial cells. Mol. Microbiol. 44:361–379.[PubMed] [CrossRef]
50. Gismero-Ordonez, J., M. Dall’Agnol, L. R. Trabulsi, and J. A. Giron. 2002. Expression of the bundle-forming pilus by enteropathogenic Escherichia coli strains of heterologous serotypes. J. Clin. Microbiol. 40:2291–2296.[PubMed] [CrossRef]
51. Gomes, T. A., M. A. Vieira, C. M. Abe, D. Rodrigues, P. M. Griffin, and S. R. Ramos. 1998. Adherence patterns and adherence-related DNA sequences in Escherichia coli isolates from children with and without diarrhea in Sao Paulo city, Brazil. J. Clin. Microbiol. 36:3609–3613.[PubMed]
52. Goncalves, N. S., C. Hale, G. Dougan, G. Frankel, and T. T. MacDonald. 2003. Binding of intimin from enteropathogenic Escherichia coli to lymphocytes and its functional consequences. Infect. Immun. 71:2960–2965.[PubMed] [CrossRef]
53. Hartland, E. L., M. Batchelor, R. M. Delahay, C. Hale, S. Matthews, G. Dougan, S. Knutton, I. Connerton, and G. Frankel. 1999. Binding of intimin from enteropathogenic Escherichia coli to Tir and to host cells. Mol. Microbiol. 32:151–158.[PubMed] [CrossRef]
54. Hawrani, A., C. E. Dempsey, M. J. Banfield, D. J. Scott, A. R. Clarke, and B. Kenny. 2003. Effect of protein kinase A-mediated phosphorylation on the structure and association properties of the enteropathogenic Escherichia coli Tir virulence protein. J. Biol. Chem. 278:25839–25846.[PubMed] [CrossRef]
55. Hazes, B., P. A. Sastry, K. Hayakawa, R. J. Read, and R. T. Irvin. 2000. Crystal structure of Pseudomonas aeruginosa PAK pilin suggests a main-chain-dominated mode of receptor binding. J. Mol. Biol. 299:1005–1017.[PubMed] [CrossRef]
56. Herrington, D. A., R. H. Hall, G. Losonsky, J. J. Mekalanos, R. K. Taylor, and M. M. Levine. 1988. Toxin, toxin-coregulated pili, and the toxR regulon are essential for Vibrio cholerae pathogenesis in humans. J. Exp. Med. 168:1487–1492.[PubMed] [CrossRef]
57. Hicks, S., G. Frankel, J. B. Kaper, G. Dougan, and A. D. Phillips. 1998. Role of intimin and bundle-forming pili in enteropathogenic Escherichia coli adhesion to pediatric intestinal tissue in vitro. Infect. Immun. 66:1570–1578.[PubMed]
58. Higgins, L. M., G. Frankel, I. Connerton, N. S. Goncalves, G. Dougan, and T. T. MacDonald. 1999. Role of bacterial intimin in colonic hyperplasia and inflammation. Science 285:588–591.[PubMed] [CrossRef]
59. Ide, T., S. Laarmann, L. Greune, H. Schillers, H. Oberleithner, and M. A. Schmidt. 2001. Characterization of translocation pores inserted into plasma membranes by type III-secreted Esp proteins of enteropathogenic Escherichia coli. Cell. Microbiol. 3:669–679.[PubMed] [CrossRef]
60. Ideses, D., D. Biran, U. Gophna, O. Levy-Nissenbaum, and E. Z. Ron. 2005. The lpf operon of invasive Escherichia coli. Int. J. Med. Microbiol. 295:227–236.[PubMed] [CrossRef]
61. Iyoda, S., and H. Watanabe. 2005. ClpXP protease controls expression of the type III protein secretion system through regulation of RpoS and GrlR levels in enterohemorrhagic Escherichia coli. J. Bacteriol. 187:4086–4094.[PubMed] [CrossRef]
62. Jagannatha, H. M., U. K. Sharma, T. Ramaseshan, A. Surolia, and T. S. Balganesh. 1991. Identification of carbohydrate structures as receptors for localised adherent enteropathogenic Escherichia coli. Microb. Pathog. 11:259–268.[PubMed] [CrossRef]
63. Jarvis, K. G., J. A. Girón, A. E. Jerse, T. K. McDaniel, M. S. Donnenberg, and J. B. Kaper. 1995. Enteropathogenic Escherichia coli contains a specialized secretion system necessary for the export of proteins involved in attaching and effacing lesion formation. Proc. Natl. Acad. Sci. USA 92:7996–8000.[PubMed] [CrossRef]
64. Jenkins, C., A. J. Lawson, T. Cheasty, G. A. Willshaw, P. Wright, G. Dougan, G. Frankel, and H. R. Smith. 2003. Subtyping intimin genes from enteropathogenic Escherichia coli associated with outbreaks and sporadic cases in the United Kingdom and Eire. Mol. Cell. Probes 17:149–156.[PubMed] [CrossRef]
65. Jepson, M. A., S. Pellegrin, L. Peto, D. N. Banbury, A. D. Leard, H. Mellor, and B. Kenny. 2003. Synergistic roles for the Map and Tir effector molecules in mediating uptake of enteropathogenic Escherichia coli (EPEC) into non-phagocytic cells. Cell. Microbiol. 5:773–783.[PubMed] [CrossRef]
66. Jerse, A. E., K. G. Gicquelais, and J. B. Kaper. 1991. Plasmid and chromosomal elements involved in the pathogenesis of attaching and effacing Escherichia coli. Infect. Immun. 59:3869–3875.[PubMed]
67. Jerse, A. E., and J. B. Kaper. 1991. The eae gene of enteropathogenic Escherichia coli encodes a 94-kilodalton membrane protein, the expression of which is influenced by the EAF plasmid. Infect. Immun. 59:4302–4309.[PubMed]
68. Jerse, A. E., J. Yu, B. D. Tall, and J. B. Kaper. 1990. A genetic locus of enteropathogenic Escherichia coli necessary for the production of attaching and effacing lesions on tissue culture cells. Proc. Natl. Acad. Sci. USA 87:7839–7843.[PubMed] [CrossRef]
69. Jordan, D. M., N. Cornick, A. G. Torres, E. A. Dean-Nystrom, J. B. Kaper, and H. W. Moon. 2004. Long polar fimbriae contribute to colonization by Escherichia coli O157:H7 in vivo. Infect. Immun. 72:6168–6171.[PubMed] [CrossRef]
70. Jores, J., K. Zehmke, J. Eichberg, L. Rumer, and L. H. Wieler. 2003. Description of a novel intimin variant (type zeta) in the bovine O84:NM verotoxin-producing Escherichia coli strain 537/89 and the diagnostic value of intimin typing. Exp. Biol. Med. (Maywood) 228:370–376.
71. Jouve, M., M. I. Garcia, P. Courcoux, A. Labigne, P. Gounon, and C. Le Bouguenec. 1997. Adhesion to and invasion of HeLa cells by pathogenic Escherichia coli carrying the afa-3 gene cluster are mediated by the AfaE and AfaD proteins, respectively. Infect. Immun. 65:4082–4089.[PubMed]
72. Kanack, K. J., J. A. Crawford, I. Tatsuno, M. A. Karmali, and J. B. Kaper. 2005. SepZ/EspZ is secreted and translocated into HeLa cells by the enteropathogenic Escherichia coli type III secretion system. Infect. Immun. 73:4327–4337.[PubMed] [CrossRef]
73. Kaper, J. B. 1996. Defining EPEC. Rev. Microbiol. Sao Paolo 27:130–133.
74. Kaper, J. B., J. P. Nataro, and H. L. Mobley. 2004. Pathogenic Escherichia coli. Nat. Rev. Microbiol. 2:123–140.[PubMed] [CrossRef]
75. Karch, H., J. Heesemann, R. Laufs, H. P. Kroll, J. B. Kaper, and M. M. Levine. 1987. Serological response to type 1-like somatic fimbriae in diarrheal infection due to classical enteropathogenic Escherichia coli. Microb. Pathog. 2:425–434.[PubMed] [CrossRef]
76. Keller, R., J. G. Ordonez, R. R. De Oliveira, L. R. Trabulsi, T. J. Baldwin, and S. Knutton. 2002. Afa, a diffuse adherence fibrillar adhesin associated with enteropathogenic Escherichia coli. Infect. Immun. 70:2681–2689.[PubMed] [CrossRef]
77. Kelly, G., S. Prasannan, S. Daniell, K. Fleming, G. Frankel, G. Dougan, I. Connerton, and S. Matthews. 1999. Structure of the cell-adhesion fragment of intimin from enteropathogenic Escherichia coli. Nat. Struct. Biol. 6:313–318.[PubMed] [CrossRef]
78. Kenny, B. 2002. Enteropathogenic Escherichia coli (EPEC)—a crafty subversive little bug. Microbiology 148:1967–1978.[PubMed]
79. Kenny, B., R. DeVinney, M. Stein, D. J. Reinscheid, E. A. Frey, and B. B. Finlay. 1997. Enteropathogenic E. coli (EPEC) transfers its receptor for intimate adherence into mammalian cells. Cell 91:511–520.[PubMed] [CrossRef]
80. Kenny, B., and M. Jepson. 2000. Targeting of an enteropathogenic Escherichia coli (EPEC) effector protein to host mitochondria. Cell. Microbiol. 2:579–590.[PubMed] [CrossRef]
81. Kirchner, M., and T. F. Meyer. 2005. The PilC adhesin of the Neisseria type IV pilus-binding specificities and new insights into the nature of the host cell receptor. Mol. Microbiol. 56:945–957.[PubMed] [CrossRef]
82. Klapproth, J. M., M. S. Donnenberg, J. M. Abraham, and S. P. James. 1996. Products of enteropathogenic E. coli inhibit lymphokine production by gastrointestinal lymphocytes. Am. J. Physiol. 271:G841–G848.[PubMed]
83. Klapproth, J. M., M. Sasaki, M. Sherman, B. Babbin, M. S. Donnenberg, P. J. Fernandes, I. C. Scaletsky, D. Kalman, A. Nusrat, and I. R. Williams. 2004. Citrobacter rodentium lifA/efa1 is essential for colonic colonization and crypt cell hyperplasia in vivo. Infect. Immun. 73:1441–1451. [CrossRef]
84. Klapproth, J. M., I. C. Scaletsky, B. P. McNamara, L. C. Lai, C. Malstrom, S. P. James, and M. S. Donnenberg. 2000. A large toxin from pathogenic Escherichia coli strains that inhibits lymphocyte activation. Infect. Immun. 68:2148–2155.[PubMed] [CrossRef]
85. Knutton, S., T. Baldwin, P. H. Williams, and A. S. McNeish. 1989. Actin accumulation at sites of bacterial adhesion to tissue culture cells: basis of a new diagnostic test for enteropathogenic and enterohemorrhagic Escherichia coli. Infect. Immun. 57:1290–1298.[PubMed]
86. Knutton, S., I. Rosenshine, M. J. Pallen, I. Nisan, B. C. Neves, C. Bain, C. Wolff, G. Dougan, and G. Frankel. 1998. A novel EspA-associated surface organelle of enteropathogenic Escherichia coli involved in protein translocation into epithelial cells. EMBO J. 17:2166–2176.[PubMed] [CrossRef]
87. Knutton, S., R. K. Shaw, R. P. Anantha, M. S. Donnenberg, and A. A. Zorgani. 1999. The type IV bundle-forming pilus of enteropathogenic Escherichia coli undergoes dramatic alterations in structure associated with bacterial adherence, aggregation and dispersal. Mol. Microbiol. 33:499–509.[PubMed] [CrossRef]
88. Lai, L.-C., L. A. Wainwright, K. D. Stone, and M. S. Donnenberg. 1997. A third secreted protein that is encoded by the enteropathogenic Escherichia coli pathogenicity island is required for transduction of signals and for attaching and effacing activities in host cells. Infect. Immun. 65:2211–2217.[PubMed]
89. Lee, K. K., H. B. Sheth, W. Y. Wong, R. Sherburne, W. Paranchych, R. S. Hodges, C. A. Lingwood, H. Krivan, and R. T. Irvin. 1994. The binding of Pseudomonas aeruginosa pili to glycosphingolipids is a tip-associated event involving the C-terminal region of the structural pilin subunit. Mol. Microbiol. 11:705–713.[PubMed] [CrossRef]
90. Liu, H., L. Magoun, and J. M. Leong. 1999. Beta1-chain integrins are not essential for intimin-mediated host cell attachment and enteropathogenic Escherichia coli-induced actin condensation. Infect. Immun. 67:2045–2049.[PubMed]
91. Liu, H., P. Radhakrishnan, L. Magoun, M. Prabu, K. G. Campellone, P. Savage, F. He, C. A. Schiffer, and J. M. Leong. 2002. Point mutants of EHEC intimin that diminish Tir recognition and actin pedestal formation highlight a putative Tir binding pocket. Mol. Microbiol. 45:1557–1573.[PubMed] [CrossRef]
92. Luo, Y., E. A. Frey, R. A. Pfuetzner, A. L. Creagh, D. G. Knoechel, C. A. Haynes, B. B. Finlay, and N. C. Strynadka. 2000. Crystal structure of enteropathogenic Escherichia coli intimin-receptor complex. Nature 405:1073–1077.[PubMed] [CrossRef]
93. Malstrom, C., and S. James. 1998. Inhibition of murine splenic and mucosal lymphocyte function by enteric bacterial products. Infect. Immun. 66:3120–3127.[PubMed]
94. Matsuzawa, T., A. Kuwae, S. Yoshida, C. Sasakawa, and A. Abe. 2004. Enteropathogenic Escherichia coli activates the RhoA signaling pathway via the stimulation of GEF-H1. EMBO J. 23:3570–3582.[PubMed] [CrossRef]
95. McDaniel, T. K., K. G. Jarvis, M. S. Donnenberg, and J. B. Kaper. 1995. A genetic locus of enterocyte effacement conserved among diverse enterobacterial pathogens. Proc. Natl. Acad. Sci. USA 92:1664–1668.[PubMed] [CrossRef]
96. McDaniel, T. K., and J. B. Kaper. 1997. A cloned pathogenicity island from enteropathogenic Escherichia coli confers the attaching and effacing phenotype on E. coli K-12. Mol. Microbiol. 23:399–407.[PubMed] [CrossRef]
97. McNamara, B. P., and M. S. Donnenberg. 1998. A novel proline-rich protein, EspF, is secreted from enteropathogenic Escherichia coli via the type III export pathway. FEMS Microbiol. Lett. 166:71–78.[PubMed] [CrossRef]
98. Mellies, J. L., S. J. Elliott, V. Sperandio, M. S. Donnenberg, and J. B. Kaper. 1999. The Per regulon of enteropathogenic Escherichia coli: identification of a regulatory cascade and a novel transcriptional activator, the locus of enterocyte effacement (LEE)-encoded regulator (Ler). Mol. Microbiol. 33:296–306.[PubMed] [CrossRef]
99. Mooi, F. R., N. Harms, D. Bakker, and F. K. de Graaf. 1981. Organization and expression of genes involved in the production of the K88ab antigen. Infect. Immun. 32:1155–1163.[PubMed]
100. Muza-Moons, M. M., A. Koutsouris, and G. Hecht. 2003. Disruption of cell polarity by enteropathogenic Escherichia coli enables basolateral membrane proteins to migrate apically and to potentiate physiological consequences. Infect. Immun. 71:7069–7078.[PubMed] [CrossRef]
101. Muza-Moons, M. M., E. E. Schneeberger, and G. A. Hecht. 2004. Enteropathogenic Escherichia coli infection leads to appearance of aberrant tight junctions strands in the lateral membrane of intestinal epithelial cells. Cell. Microbiol. 6:783–793.[PubMed] [CrossRef]
102. Nagai, T., A. Abe, and C. Sasakawa. 2005. Targeting of enteropathogenic Escherichia coli EspF to host mitochondria is essential for bacterial pathogenesis: critical role of the 16th leucine residue in EspF. J. Biol. Chem. 280:2998–3011.[PubMed] [CrossRef]
103. Nataro, J. P., and J. B. Kaper. 1998. Diarrheagenic Escherichia coli. Clin. Microbiol. Rev. 11:142–201.[PubMed]
104. Neves, B. C., R. Mundy, L. Petrovska, G. Dougan, S. Knutton, and G. Frankel. 2003. CesD2 of enteropathogenic Escherichia coli is a second chaperone for the type III secretion translocator protein EspD. Infect. Immun. 71:2130–2141.[PubMed] [CrossRef]
105. Newton, H. J., J. Sloan, V. Bennett-Wood, L. M. Adams, R. M. Robins-Browne, and E. L. Hartland. 2004. Contribution of long polar fimbriae to the virulence of rabbit-specific enteropathogenic Escherichia coli. Infect. Immun. 72:1230–1239.[PubMed] [CrossRef]
106. Nicholls, L., T. H. Grant, and R. M. Robins-Browne. 2000. Identification of a novel genetic locus that is required for in vitro adhesion of a clinical isolate of enterohaemorrhagic Escherichia coli to epithelial cells. Mol. Microbiol. 35:275–288.[PubMed] [CrossRef]
107. Nougayrede, J. P., and M. S. Donnenberg. 2004. Enteropathogenic Escherichia coli EspF is targeted to mitochondria and is required to initiate the mitochondrial death pathway. Cell. Microbiol. 6:1097–1111.[PubMed] [CrossRef]
108. Nougayrede, J. P., P. J. Fernandes, and M. S. Donnenberg. 2003. Adhesion of enteropathogenic Escherichia coli to host cells. Cell. Microbiol. 5:359–372.[PubMed] [CrossRef]
109. O’Ryan, M., V. Prado, and L. K. Pickering. 2005. A millennium update on pediatric diarrheal illness in the developing world. Semin. Pediatr. Infect. Dis. 16:125–136.[PubMed] [CrossRef]
110. Oswald, E., H. Schmidt, S. Morabito, H. Karch, O. Marches, and A. Caprioli. 2000. Typing of intimin genes in human and animal enterohemorrhagic and enteropathogenic Escherichia coli: characterization of a new intimin variant. Infect. Immun. 68:64–71.[PubMed] [CrossRef]
111. Pelayo, J. S., I. C. Scaletsky, M. Z. Pedroso, V. Sperandio, J. A. Giron, G. Frankel, and L. R. Trabulsi. 1999. Virulence properties of atypical EPEC strains. J. Med. Microbiol. 48:41–49.[PubMed] [CrossRef]
112. Phillips, A. D., and G. Frankel. 2000. Intimin-mediated tissue specificity in enteropathogenic Escherichia coli interaction with human intestinal organ cultures. J. Infect. Dis. 181:1496–1500.[PubMed] [CrossRef]
113. Phillips, A. D., J. Giron, S. Hicks, G. Dougan, and G. Frankel. 2000. Intimin from enteropathogenic Escherichia coli mediates remodelling of the eukaryotic cell surface. Microbiology 146:1333–1344.[PubMed]
114. Phillips, A. D., S. Navabpour, S. Hicks, G. Dougan, T. Wallis, and G. Frankel. 2000. Enterohaemorrhagic Escherichia coli O157:H7 target Peyer's patches in humans and cause attaching/effacing lesions in both human and bovine intestine. Gut 47:377–381.[PubMed] [CrossRef]
115. Rabinowitz, R. P., L. C. Lai, K. Jarvis, T. K. McDaniel, J. B. Kaper, K. D. Stone, and M. S. Donnenberg. 1996. Attaching and effacing of host cells by enteropathogenic Escherichia coli in the absence of detectable tyrosine kinase mediated signal transduction. Microb. Pathog. 21:157–171.[PubMed] [CrossRef]
116. Ramboarina, S., P. Fernandes, P. Simpson, G. Frankel, M. Donnenberg, and S. Matthews. 2004. Complete resonance assignments of bundlin (BfpA) from the bundle-forming pilus of enteropathogenic Escherichia coli. J. Biomol. NMR 29:427–428.[PubMed] [CrossRef]
117. Ramer, S. W., D. Bieber, and G. K. Schoolnik. 1996. BfpB, an outer membrane lipoprotein required for the biogenesis of bundle-forming pili in enteropathogenic Escherichia coli. J. Bacteriol. 178:6555–6563.[PubMed]
118. Ramer, S. W., G. K. Schoolnik, C. Y. Wu, J. Hwang, S. A. Schmidt, and D. Bieber. 2002. The type IV pilus assembly complex: biogenic interactions among the bundle-forming pilus proteins of enteropathogenic Escherichia coli. J. Bacteriol. 184:3457–3465.[PubMed] [CrossRef]
119. Rosenshine, I., S. Ruschkowski, M. Stein, D. J. Reincheid, S. D. Mills, and B. B. Finlay. 1996. A pathogenic bacterium triggers epithelial signals to form a functional bacterial receptor that mediates actin pseudopod formation. EMBO J. 15:2613–2624.[PubMed]
120. Rothbaum, R. J., J. C. Partin, K. Saalfield, and A. J. McAdams. 1983. An ultrastructural study of enteropathogenic Escherichia coli infection in human infants. Ultrastruct. Pathol. 4:291–304.[PubMed] [CrossRef]
121. Rudel, T., I. Scheuerpflug, and T. F. Meyer. 1995. Neisseria PilC protein identified as type-4 pilus tip-located adhesin. Nature 373:357–359.[PubMed] [CrossRef]
122. Scaletsky, I. C., J. Michalski, A. G. Torres, M. V. Dulguer, and J. B. Kaper. 2005. Identification and characterization of the locus of diffuse adhesion (LDA), a novel adherence locus found in atypical enteropathogenic Escherichia coli. Infect. Immun. 73:4753–4765.[PubMed] [CrossRef]
123. Scaletsky, I. C., S. R. Milani, L. R. Trabulsi, and L. R. Travassos. 1988. Isolation and characterization of the localized adherence factor of enteropathogenic Escherichia coli. Infect. Immun. 56:2979–2983.[PubMed]
124. Scaletsky, I. C., M. L. M. Silva, and L. R. Trabulsi. 1984. Distinctive patterns of adherence of enteropathogenic Escherichia coli to HeLa cells. Infect. Immun. 45:534–536.[PubMed]
125. Schmidt, S. A., D. Bieber, S. W. Ramer, J. Hwang, C. Y. Wu, and G. Schoolnik. 2001. Structure-function analysis of BfpB, a secretin-like protein encoded by the bundle-forming-pilus operon of enteropathogenic Escherichia coli. J. Bacteriol. 183:4848–4859.[PubMed] [CrossRef]
126. Schreiber, W., K. D. Stone, M. A. Strong, L. J. J. DeTolla, M. Hoppert, and M. S. Donnenberg. 2002. BfpU, a soluble protein essential for type IV pilus biogenesis in enteropathogenic Escherichia coli. Microbiology 148:2507–2518.[PubMed]
127. Sekiya, K., M. Ohishi, T. Ogino, K. Tamano, C. Sasakawa, and A. Abe. 2001. Supermolecular structure of the enteropathogenic Escherichia coli type III secretion system and its direct interaction with the EspA-sheath-like structure. Proc. Natl. Acad. Sci. USA 98:11638–11643.[PubMed] [CrossRef]
128. Shaw, R. K., J. Cleary, M. S. Murphy, G. Frankel, and S. Knutton. 2005. Interaction of enteropathogenic Escherichia coli with human intestinal mucosa: role of effector proteins in brush border remodeling and formation of attaching and effacing lesions. Infect. Immun. 73:1243–1251.[PubMed] [CrossRef]
129. Shaw, R. K., S. Daniell, F. Ebel, G. Frankel, and S. Knutton. 2001. EspA filament-mediated protein translocation into red blood cells. Cell. Microbiol. 3:213–222.[PubMed] [CrossRef]
130. Shaw, R. K., K. Smollett, J. Cleary, J. Garmendia, A. Straatman-Iwanowska, G. Frankel, and S. Knutton. 2005. Enteropathogenic Escherichia coli type III effectors EspG and EspG2 disrupt the microtubule network of intestinal epithelial cells. Infect. Immun. 73:4385–4390.[PubMed] [CrossRef]
131. Sinclair, J. F., and A. D. O’Brien. 2002. Cell surface-localized nucleolin is a eukaryotic receptor for the adhesin intimin-gamma of enterohemorrhagic Escherichia coli O157:H7. J. Biol. Chem. 277:2876–2885.[PubMed] [CrossRef]
132. Sinclair, J. F., and A. D. O’Brien. 2004. Intimin types alpha, beta, and gamma bind to nucleolin with equivalent affinity but lower avidity than to the translocated intimin receptor. J. Biol. Chem. 279:33751–33758.[PubMed] [CrossRef]
133. Sohel, I., J. L. Puente, S. W. Ramer, D. Bieber, C. Y. Wu, and G. K. Schoolnik. 1996. Enteropathogenic Escherichia coli: identification of a gene cluster coding for bundle-forming pilus morphogenesis. J. Bacteriol. 178:2613–2628.[PubMed]
134. Stone, K. D., H. Z. Zhang, L. K. Carlson, and M. S. Donnenberg. 1996. A cluster of fourteen genes from enteropathogenic Escherichia coli is sufficient for the biogenesis of a type IV pilus. Mol. Microbiol. 20:325–337.[PubMed] [CrossRef]
135. Swimm, A., B. Bommarius, Y. Li, D. Cheng, P. Reeves, M. Sherman, D. Veach, W. Bornmann, and D. Kalman. 2004. Enteropathogenic Escherichia coli use redundant tyrosine kinases to form actin pedestals. Mol. Biol. Cell 15:3520–3529.[PubMed] [CrossRef]
136. Tamamoto, T., K. Nakashima, N. Nakasone, Y. Honma, N. Higa, and T. Yamashiro. 1998. Adhesive property of toxin-coregulated pilus of Vibrio cholerae O1. Microbiol. Immunol. 42:41–45.[PubMed]
137. Tarr, C. L., and T. S. Whittam. 2002. Molecular evolution of the intimin gene O111 clones of pathogenic Escherichia coli. J. Bacteriol. 184:479–487.[PubMed] [CrossRef]
138. Tatsuno, I., M. Horie, H. Abe, T. Miki, K. Makino, H. Shinagawa, H. Taguchi, S. Kamiya, T. Hayashi, and C. Sasakawa. 2001. toxB gene on pO157 of enterohemorrhagic Escherichia coli O157:H7 is required for full epithelial cell adherence phenotype. Infect. Immun. 69:6660–6669.[PubMed] [CrossRef]
139. Tatsuno, I., R. Mundy, G. Frankel, Y. Chong, A. D. Phillips, A. G. Torres, and J. B. Kaper. 2006. The lpf gene cluster for long polar fimbriae is not involved in adherence of enteropathogenic Escherichia coli or virulence of Citrobacter rodentium. Infect. Immun. 74:265–272. [PubMed] [CrossRef]
140. Taylor, K. A., C. B. O’Connell, P. W. Luther, and M. S. Donnenberg. 1998. The EspB protein of enteropathogenic Escherichia coli is targeted to the cytoplasm of infected HeLa cells. Infect. Immun. 66:5501–5507.[PubMed]
141. Tobe, T., and C. Sasakawa. 2001. Role of bundle-forming pilus of enteropathogenic Escherichia coli in host cell adherence and in microcolony development. Cell. Microbiol. 3:579–585.[PubMed] [CrossRef]
142. Tobe, T., and C. Sasakawa. 2002. Species-specific cell adhesion of enteropathogenic Escherichia coli is mediated by type IV bundle-forming pili. Cell. Microbiol. 4:29–42.[PubMed] [CrossRef]
143. Tobe, T., G. K. Schoolnik, I. Sohel, V. H. Bustamante, and J. L. Puente. 1996. Cloning and characterization of bfpTVW, genes required for the transcriptional activation of bfpA in enteropathogenic Escherichia coli. Mol. Microbiol. 21:963–975.[PubMed] [CrossRef]
144. Tomson, F. L., V. K. Viswanathan, K. J. Kanack, R. P. Kanteti, K. V. Straub, M. Menet, J. B. Kaper, and G. Hecht. 2005. Enteropathogenic Escherichia coli EspG disrupts microtubules and in conjunction with Orf3 enhances perturbation of the tight junction barrier. Mol. Microbiol. 56:447–464.[PubMed] [CrossRef]
145. Torres, A. G., J. A. Giron, N. T. Perna, V. Burland, F. R. Blattner, F. Avelino-Flores, and J. B. Kaper. 2002. Identification and characterization of lpfABCC’DE, a fimbrial operon of enterohemorrhagic Escherichia coli O157:H7. Infect. Immun. 70:5416–5427.[PubMed] [CrossRef]
146. Torres, A. G., K. J. Kanack, C. B. Tutt, V. Popov, and J. B. Kaper. 2004. Characterization of the second long polar (LP) fimbriae of Escherichia coli O157:H7 and distribution of LP fimbriae in other pathogenic E. coli strains. FEMS Microbiol. Lett. 238:333–344.[PubMed] [CrossRef]
147. Torres, A. G., and J. B. Kaper. 2001. PAIs of intestinal E. coli, p. 31–48. In J. Hacker and J. B. Kaper (ed.), Pathogenicity Islands (PAIs) and the Evolution of Pathogenic Microbes, vol. 1. Springer-Verlag, Berlin, Germany.
148. Torres, A. G., X. Zhou, and J. B. Kaper. 2005. Adherence of diarrheagenic Escherichia coli strains to epithelial cells. Infect. Immun. 73:18–29.[PubMed] [CrossRef]
149. Touze, T., R. D. Hayward, J. Eswaran, J. M. Leong, and V. Koronakis. 2004. Self-association of EPEC intimin mediated by the beta-barrel-containing anchor domain: a role in clustering of the Tir receptor. Mol. Microbiol. 51:73–87.[PubMed] [CrossRef]
150. Trabulsi, L. R., R. Keller, and T. A. T. Gomes. 2002. Typical and atypical enteropathogenic Escherichia coli (EPEC). Emerg. Infect. Dis. 8:508–513.[PubMed]
151. Tu, X., I. Nisan, C. Yona, E. Hanski, and I. Rosenshine. 2003. EspH, a new cytoskeleton-modulating effector of enterohaemorrhagic and enteropathogenic Escherichia coli. Mol. Microbiol. 47:595–606.[PubMed] [CrossRef]
152. Valle, G. R., T. A. T. Gomes, K. Irino, and L. R. Trabulsi. 1997. The traditional enteropathogenic Escherichia coli (EPEC) serogroup O125 comprises serotypes which are mainly associated with the category of enteroaggregative E. coli. FEMS Microbiol. Lett. 152:95–100.[PubMed] [CrossRef]
153. Vanmaele, R. P., L. D. Heerze, and G. D. Armstrong. 1999. Role of lactosyl glycan sequences in inhibiting enteropathogenic Escherichia coli attachment. Infect. Immun. 67:3302–3307.[PubMed]
154. Vuopio-Varkila, J., and G. K. Schoolnik. 1991. Localized adherence by enteropathogenic Escherichia coli is an inducible phenotype associated with the expression of new outer membrane proteins. J. Exp. Med. 174:1167–1177.[PubMed] [CrossRef]
155. Wachter, C., C. Beinke, M. Mattes, and M. A. Schmidt. 1999. Insertion of EspD into epithelial target cell membranes by infecting enteropathogenic Escherichia coli. Mol. Microbiol. 31:1695–1707.[PubMed] [CrossRef]
156. Warawa, J., B. B. Finlay, and B. Kenny. 1999. Type III secretion-dependent hemolytic activity of enteropathogenic Escherichia coli. Infect. Immun. 67:5538–5540.[PubMed]
157. Whittam, T. S., M. L. Wolfe, I. K. Wachsmuth, F. Orskov, I. Orskov, and R. A. Wilson. 1993. Clonal relationships among Escherichia coli strains that cause hemorrhagic colitis and infantile diarrhea. Infect. Immun. 61:1619–1629.[PubMed]
158. Wolff, C., I. Nisan, E. Hanski, G. Frankel, and I. Rosenshine. 1998. Protein translocation into host epithelial cells by infecting enteropathogenic Escherichia coli. Mol. Microbiol. 28:143–155.[PubMed] [CrossRef]
159. Wu, Y., B. Lau, S. Smith, K. Troyan, and D. E. Barnett Foster. 2004. Enteropathogenic Escherichia coli infection triggers host phospholipid metabolism perturbations. Infect. Immun. 72:6764–6772.[PubMed] [CrossRef]
160. Yona-Nadler, C., T. Umanski, S. I. Aizawa, D. Friedberg, and I. Rosenshine. 2003. Integration host factor (IHF) mediates repression of flagella in enteropathogenic and enterohemorrhagic Escherichia coli. Microbiology 149:877–884.[PubMed] [CrossRef]
161. Zhang, H. Z., and M. S. Donnenberg. 1996. DsbA is required for stability of the type IV pilin of enteropathogenic Escherichia coli. Mol. Microbiol. 21:787–797.[PubMed] [CrossRef]
162. Zhang, H. Z., S. Lory, and M. S. Donnenberg. 1994. A plasmid-encoded prepilin peptidase gene from enteropathogenic Escherichia coli. J. Bacteriol. 176:6885–6891.[PubMed]
163. Zhang, W. L., B. Köhler, E. Oswald, L. Beutin, H. Karch, S. Morabito, A. Caprioli, S. Suerbaum, and H. Schmidt. 2002. Genetic diversity of intimin genes of attaching and effacing Escherichia coli strains. J. Clin. Microbiol. 40:4486–4492.[PubMed] [CrossRef]
164. Zhou, X., J. A. Girón, A. G. Torres, J. A. Crawford, E. Negrete, S. N. Vogel, and J. B. Kaper. 2003. Flagellin of enteropathogenic Escherichia coli stimulates interleukin-8 production in T84 cells. Infect. Immun. 71:2120–2129.[PubMed] [CrossRef]
165. Zhu, C., T. S. Agin, S. J. Elliott, L. A. Johnson, T. E. Thate, J. B. Kaper, and E. C. Boedeker. 2001. Complete nucleotide sequence and analysis of the locus of enterocyte effacement from rabbit diarrheagenic Escherichia coli RDEC-1. Infect. Immun. 69:2107–2115.[PubMed] [CrossRef]